| HXB2 Stock | | | EUR 0.36 0.01 2.86% |
AIM IMMUNOTECH risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for AIM IMMUNOTECH INC or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
AIM IMMUNOTECH INC has current Risk Adjusted Performance of 0.037.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0.037 | |
AIM IMMUNOTECH Risk Adjusted Performance Peers Comparison
AIM Risk Adjusted Performance Relative To Other Indicators
AIM IMMUNOTECH INC is rated
# 2 in risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about
1,669 of Maximum Drawdown per Risk Adjusted Performance. The ratio of Maximum Drawdown to Risk Adjusted Performance for AIM IMMUNOTECH INC is roughly
1,669
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
